Enhancing breast cancer treatment: Comprehensive study of gefitinib-loaded poloxamer 407/TPGS mixed micelles through design, development, in-silico modelling, In-Vitro testing, and Ex-Vivo characterization
Padakanti Sandeep Chary(National Institute of Pharmaceutical Education and Research - Ahmedabad), Neelesh Kumar Mehra(National Institute of Pharmaceutical Education and Research), Santosh Kumar Guru, Valamla Bhavana(National Institute of Pharmaceutical Education and Research), Siva Singothu(National Institute of Pharmaceutical Education and Research), Anamika Sharma(National Institute of Pharmaceutical Education and Research), Vasundhra Bhandari(National Institute of Animal Biotechnology), Ankush Bansode, Naveen Rajana(National Institute of Pharmaceutical Education and Research)
Cited by 34
Related Papers
Multifunctional hybrid nanoparticles in diagnosis and therapy of breast cancer
|Journal of Controlled Release|2022|84
Prevalence and Characterization of Oxacillin Susceptible mecA-Positive Clinical Isolates of Staphylococcus aureus Causing Bovine Mastitis in India
|PLoS ONE|2016|70
Outer Membrane Vesicles: An Emerging Vaccine Platform
|Vaccines|2022|59
Targeted delivery and apoptosis induction of CDK-4/6 inhibitor loaded folic acid decorated lipid-polymer hybrid nanoparticles in breast cancer cells
|International Journal of Pharmaceutics|2024|38
Development and evaluation of nanocrystals loaded hydrogel for topical application
|Journal of Drug Delivery Science and Technology|2022|34